Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 296

    1.

    Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

    Snow V, Aronson MD, Hornbake ER, Mottur-Pilson C, Weiss KB; Clinical Efficacy Assessment Subcommittee of the American College of Physicians.

    Ann Intern Med. 2004 Apr 20;140(8):644-9.PMID: 15096336 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

    Vijan S, Hayward RA; American College of Physicians.

    Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.PMID: 15096337 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Control of lipids in patients with type 2 diabetes: recommendations from the American College of Physicians.

    [No authors listed]

    Ann Intern Med. 2004 Apr 20;140(8):I85. No abstract available. PMID: 15096362 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

    Evans M, Roberts A, Davies S, Rees A.

    Drugs. 2004;64(11):1181-96. Review.PMID: 15161326 [PubMed - indexed for MEDLINE]Related articles

    5.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.PMID: 15358046 [PubMed - indexed for MEDLINE]Related articles

    6.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.PMID: 15297292 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

    Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763. PMID: 15249516 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators.

    Lancet. 2004 Aug 21-27;364(9435):685-96.PMID: 15325833 [PubMed - indexed for MEDLINE]Related articles

    9.

    Patterns and predictors of statin prescription in patients with type 2 diabetes.

    Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP.

    Cardiovasc Diabetol. 2009 May 13;8:25.PMID: 19439071 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Care of adults with type 2 diabetes mellitus. A review of the evidence.

    O'Connor PJ, Spann SJ, Woolf SH.

    J Fam Pract. 1998 Nov;47(5 Suppl):S13-22. Review.PMID: 9834750 [PubMed - indexed for MEDLINE]Related articles

    11.

    Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.

    Steinmetz A.

    Diabetes Metab Res Rev. 2008 May-Jun;24(4):286-93. Review.PMID: 18273835 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improving macrovascular outcomes in type 2 diabetes: Outcome studies in cardiovascular risk and metabolic control.

    Schneider CA.

    Curr Med Res Opin. 2006;22 Suppl 2:S15-26. Review.PMID: 16914072 [PubMed - indexed for MEDLINE]Related articles

    13.

    Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association.

    Woolf SH, Davidson MB, Greenfield S, Bell HS, Ganiats TG, Hagen MD, Palda VA, Rizza RA, Spann SJ.

    J Fam Pract. 2000 May;49(5):453-60. Review.PMID: 10836779 [PubMed - indexed for MEDLINE]Related articles

    14.

    A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

    Tuomilehto J, Leiter LA, Kallend D.

    Int J Clin Pract Suppl. 2004 Oct;(143):30-40. Review.PMID: 16035394 [PubMed - indexed for MEDLINE]Related articles

    15.
    16.

    Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong.

    Lee VW, Ho IC, Chan WS, Tam KY, Lee KK.

    Am J Cardiovasc Drugs. 2008;8(3):199-205.PMID: 18533740 [PubMed - indexed for MEDLINE]Related articles

    17.

    How to ADVANCE prevention of cardiovascular complications in type 2 diabetes.

    Grobbee DE.

    Metabolism. 2003 Aug;52(8 Suppl 1):24-8. Review.PMID: 12939736 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cholesterol management in high-risk patients without heart disease. When is lipid-lowering medication warranted for primary prevention?

    Grundy SM.

    Postgrad Med. 1998 Nov;104(5):117-20, 123-4, 129. Review.PMID: 9823389 [PubMed - indexed for MEDLINE]Related articles

    19.

    Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus.

    Riche DM, McClendon KS.

    Am J Health Syst Pharm. 2007 Aug 1;64(15):1603-10. Review.PMID: 17646562 [PubMed - indexed for MEDLINE]Related articles

    20.

    High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.

    Gonzalez GL, Manrique CM, Sowers JR.

    J Cardiometab Syndr. 2006 Summer;1(3):178-83. Review.PMID: 17679817 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data